Unknown

Dataset Information

0

Mapping RNA splicing variations in clinically accessible and nonaccessible tissues to facilitate Mendelian disease diagnosis using RNA-seq.


ABSTRACT:

Purpose

RNA-seq is a promising approach to improve diagnoses by detecting pathogenic aberrations in RNA splicing that are missed by DNA sequencing. RNA-seq is typically performed on clinically accessible tissues (CATs) from blood and skin. RNA tissue specificity makes it difficult to identify aberrations in relevant but nonaccessible tissues (non-CATs). We determined how RNA-seq from CATs represent splicing in and across genes and non-CATs.

Methods

We quantified RNA splicing in 801 RNA-seq samples from 56 different adult and fetal tissues from Genotype-Tissue Expression Project (GTEx) and ArrayExpress. We identified genes and splicing events in each non-CAT and determined when RNA-seq in each CAT would inadequately represent them. We developed an online resource, MAJIQ-CAT, for exploring our analysis for specific genes and tissues.

Results

In non-CATs, 40.2% of genes have splicing that is inadequately represented by at least one CAT; 6.3% of genes have splicing inadequately represented by all CATs. A majority (52.1%) of inadequately represented genes are lowly expressed in CATs (transcripts per million (TPM) < 1), but 5.8% are inadequately represented despite being well expressed (TPM > 10).

Conclusion

Many splicing events in non-CATs are inadequately evaluated using RNA-seq from CATs. MAJIQ-CAT allows users to explore which accessible tissues, if any, best represent splicing in genes and tissues of interest.

SUBMITTER: Aicher JK 

PROVIDER: S-EPMC7335339 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mapping RNA splicing variations in clinically accessible and nonaccessible tissues to facilitate Mendelian disease diagnosis using RNA-seq.

Aicher Joseph K JK   Jewell Paul P   Vaquero-Garcia Jorge J   Barash Yoseph Y   Bhoj Elizabeth J EJ  

Genetics in medicine : official journal of the American College of Medical Genetics 20200330 7


<h4>Purpose</h4>RNA-seq is a promising approach to improve diagnoses by detecting pathogenic aberrations in RNA splicing that are missed by DNA sequencing. RNA-seq is typically performed on clinically accessible tissues (CATs) from blood and skin. RNA tissue specificity makes it difficult to identify aberrations in relevant but nonaccessible tissues (non-CATs). We determined how RNA-seq from CATs represent splicing in and across genes and non-CATs.<h4>Methods</h4>We quantified RNA splicing in 80  ...[more]

Similar Datasets

| S-EPMC2736440 | biostudies-literature
| S-EPMC10767883 | biostudies-literature
| S-EPMC6032541 | biostudies-literature
| S-EPMC3936741 | biostudies-literature
| S-EPMC7263396 | biostudies-literature
| S-EPMC10707456 | biostudies-literature
| S-EPMC3017616 | biostudies-literature
| S-EPMC4132698 | biostudies-literature
| S-EPMC7977290 | biostudies-literature
| S-EPMC8874219 | biostudies-literature